NCT07013812View on ClinicalTrials.gov

Tranexamic Acid to Reduce Blood Loss in Women Having Planned Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Cesarean SectionBlood Loss During Surgery
Interventions
DRUG

Tranexamic Acid (IV)

One gram (10 ml) intravenous injection

DRUG

Dextrose 5% (D5W)

5% dextrose water intravenously

Trial Locations (1)

60000

Combined Military Hospital, Multan

All Listed Sponsors
lead

Combined Military Hospital Multan

OTHER

NCT07013812 - Tranexamic Acid to Reduce Blood Loss in Women Having Planned Cesarean Section | Biotech Hunter | Biotech Hunter